Patent · US Active

Benzo[1,2,5]thiadiazole compounds

US7550492B2 · kind B2 · utility

0Cited by

2References

2Claims

0Family size

Assignee

Janssen Pharmaceutica NA · BE

Inventors

Brett D. Allison · Del Mar, US
Laura C. McAfee · King of Prussia, US
Victor K. Phuong · San Diego, US
Michael H. Rabinowitz · San Diego, US
Nigel P. Shankley · Edenbridge, GB

Key dates

Filing date	Jul 10, 2007
Grant date	Jun 23, 2009
Priority date	—
Expiry date	Jul 10, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Certain amidophenyl-sulfanylamino-benzo[1,2,5]thiadiazole compounds are CCK2 modulators useful in the treatment of CCK2 mediated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.